2,531 results match your criteria: "Nantes University.[Affiliation]"
Intensive Care Med
October 2024
Department of Infectious Diseases, University Hospital of Nantes and Centre d'Investigation Clinique 1413, INSERM, Nantes, France.
Front Bioeng Biotechnol
July 2024
Human Movement Biomechanics Research Group, Department of Movement Science, KU Leuven, Leuven, Belgium.
The Achilles tendon exhibits anatomical variations in subtendon twist among individuals, and its compliance can change due to conditions like Achilles tendinopathy. However, current musculoskeletal models overlook these material and morphological variations. This study aimed to investigate the impact of altering Achilles subtendon insertion points and compliance on the triceps surae muscle forces, and therefore tendon loading, during dynamic exercises in one Achilles tendinopathy patient.
View Article and Find Full Text PDFHeliyon
July 2024
German Aerospace Center (DLR), Institute of Structures and Design, Center for Lightweight Production Technology, Augsburg, Germany.
The Cameroon has two bamboo species indigenous to Africa (the and the ), and one largely exotic species, . However, little on their physical characteristics and strength for the composites materials applications is known for these two indigenous bamboos species in Cameroon. Therefore, in this study, emphasis was laid on the alpine bamboo , to evaluate its potential for biocomposites applications.
View Article and Find Full Text PDFJCI Insight
August 2024
Nantes Université, Univ Angers, INSERM, CNRS, Immunology and New Concepts in ImmunoTherapy, INCIT,UMR 1302, F-44000 Nantes, France.
Ann Intensive Care
July 2024
Medical ICU, Saint-Louis University Hospital, AP-HP, 1 Avenue Claude Vellefaux, Paris, 75010, France.
Background: The accuracy of a diagnostic test depends on its intrinsic characteristics and the disease incidence. This study aims to depict post-test probability of Pneumocystis pneumonia (PJP), according to results of PCR and Beta-D-Glucan (BDG) tests in patients with acute respiratory failure (ARF).
Materials And Methods: Diagnostic performance of PCR and BDG was extracted from literature.
Lancet Reg Health Eur
July 2024
Obstetrical, Perinatal and Pediatric Epidemiology Research Team, Centre of Research in Epidemiology and StatisticS, Université Paris Cité, INSERM, F-75014, Paris, France.
Eur J Pediatr
October 2024
Pediatric Intensive Care, Hôpital Femme Mère Enfant, Hospices Civils de Lyon, 59 Bd Pinel, 69500, Lyon-Bron, France.
In hospitalized children, height should be measured. When world health organization (WHO) height measurement gold standards is impossible, the ideal height estimation technique is still unclear. We conducted an international prospective study in eight different pediatric intensive care units to assess the accuracy, precision, practicability, safety, and inter-rater reliability of 12 different height estimation techniques, based on body segment measurement extrapolation, or other calculations using previous or projected heights.
View Article and Find Full Text PDFBlood
November 2024
Division of Pediatric Hematology and Oncology, Hospital Universitari Vall d'Hebron and Vall d'Hebron Institute of Research, Barcelona, Spain.
In REACH4, a phase 1/2, open-label, single-arm, multicenter study, the pharmacokinetics (PK), efficacy, and safety of ruxolitinib were evaluated in treatment-naïve and steroid-refractory pediatric patients with grade 2 to 4 acute graft-versus-host disease (aGVHD; n = 45). Ruxolitinib dosing was based on age and targeted the exposure in adults receiving 10 mg twice daily; group 1 (aged ≥12 to <18 years) received 10 mg twice daily and preliminary starting doses for groups 2 (aged ≥6 to <12 years) and 3 (aged ≥2 to <6 years) were 5 mg twice daily and 4 mg/m2 twice daily, respectively. The phase 1 primary objective was to assess ruxolitinib PK parameters and define an age-appropriate recommended phase 2 dose (RP2D) for patients aged <12 years.
View Article and Find Full Text PDFAnn Dermatol Venereol
September 2024
Centre of Evidence of The French Society of Dermatology, Paris, France; Dermatology, Univ Montpellier, Montpellier, France.
Background: New highly effective drugs for moderate-to-severe cutaneous psoriasis are regularly marketed, and the hierarchy of treatments thus requires frequent review.
Objectives: A Delphi method was used to enable a structured expert consensus on the use of systemic treatments and phototherapy among adults with moderate-to-severe psoriasis.
Methods: The Delphi method consists in achieving a convergence of opinions among a panel of experts using several rounds of questionnaires with controlled feedback between rounds.
EClinicalMedicine
July 2024
Department of Dermatology, Saint-Louis Hospital, AP-HP, Paris, France.
Oncoimmunology
July 2024
Nantes Université, Inserm UMR 1307, CNRS UMR 6075, Université d'Angers, Nantes, France.
Attenuated measles virus (MV) exerts its oncolytic activity in malignant pleural mesothelioma (MPM) cells that lack type-I interferon (IFN-I) production or responsiveness. However, other cells in the tumor microenvironment (TME), such as myeloid cells, possess functional antiviral pathways. In this study, we aimed to characterize the interplay between MV and the myeloid cells in human MPM.
View Article and Find Full Text PDFArch Pediatr
August 2024
Nantes University, CHU Nantes, Pharmacy, F-44000, France; Paris Cité University, Inserm, ECEVE, F-75010, Paris, France.
Ann Dermatol Venereol
September 2024
National Reference Center for PXE (MAGEC Nord), Dept. of Dermatology, Angers University Hospital, F-49000 Angers, France; Angers University, MitoVasc (INSERM U1083, CNRS 6015), SFR ICAT, F-49000 Angers, France. Electronic address:
J Thromb Haemost
October 2024
Hematology and Transfusion Department, Institut National de la Santé et de la Recherche Médicale, Centre Hospitalier Universitaire de Lille, Institut Pasteur de Lille, Université de Lille, U1011-European Genomic Institute for Diabetes, Lille, France. Electronic address:
PLoS One
July 2024
Department of Economics and Business Economics, Aarhus University, Aarhus, Denmark.
Child maltreatment is a widespread problem with significant costs for both victims and society. In this retrospective cohort study, we develop predictive risk models using Danish administrative data to predict removal decisions among referred children and assess the effectiveness of caseworkers in identifying children at risk of maltreatment. The study analyzes 195,639 referrals involving 102,309 children Danish Child Protection Services received from April 2016 to December 2017.
View Article and Find Full Text PDFAnn Intensive Care
July 2024
Intensive Care Unit, Nantes University Hospital, Nantes University, 30 Bd. Jean Monnet, Nantes, Cedex 1 44093, France.
Hemasphere
July 2024
Department of Pediatric Hematology CHU Hôtel Dieu Nantes France.
For most patients with childhood myelodysplastic syndrome (cMDS), allogeneic hematopoietic stem cell transplantation (allo-HSCT) remains the only curative option. In the case of increased blasts (cMDS-IB), the benefit of pretransplant cytoreductive therapy remains controversial. In this multicenter retrospective study, the outcomes of all French children who underwent allo-HSCT for cMDS reported in the SFGM-TC registry between 2000 and 2020 were analyzed ( = 84).
View Article and Find Full Text PDFHum Vaccin Immunother
December 2024
Hematology Department, Nantes University Hospital, Nantes, France.
The impact of pre-graft COVID-19 vaccinations in donor or recipient as well as pre-graft infection has been studied in 157 adults having received allogeneic stem cell transplantation (Allo-SCT) for various hematological diseases during the delta/omicron waves. We showed here that pre-Allo-SCT COVID-19 vaccination and/or infection do not provide more protection in patients receiving vaccine, immunotherapy or both after transplant. COVID-19 vaccination is and remains of crucial importance after Allo-SCT, reinforcing the recommendation to start COVID-19 vaccination as soon as the third month following the transplant.
View Article and Find Full Text PDFAIDS Care
August 2024
Department of Infectious Diseases, Nantes University Hospital, University of Nantes, Nantes, France.
The secrecy surrounding HIV continues to be a major concern for older people living with HIV (OPWH) despite their long-term experience of HIV and the presence of other chronic diseases. Our study aims to highlight how the secrecy surrounding HIV can affect the management of the other conditions. The results of this socio-anthropological sub-study of the ANRS EP66 SEPTAVIH study, which assesses frailty in OPWH, are based on in-depth interviews conducted with 20 OPWH with multimorbidities aged 70 years and over and 9 caregivers.
View Article and Find Full Text PDFOpen Forum Infect Dis
July 2024
INSERM, EA1413, Nantes, France.
Background: People with HIV (PWH) are aging. Frailty is an age-related condition predictive of hospitalization and mortality. Here, we assessed the frequency and factors associated with frailty transitions at 1-year follow-up in elderly PWH.
View Article and Find Full Text PDFEur J Neurol
September 2024
Department of Neurology, Johns Hopkins University, Baltimore, Vermont, USA.
Background And Purpose: Various electrodiagnostic criteria have been developed in Guillain-Barré syndrome (GBS). Their performance in a broad representation of GBS patients has not been evaluated. Motor conduction data from the International GBS Outcome Study (IGOS) cohort were used to compare two widely used criterion sets and relate these to diagnostic amyotrophic lateral sclerosis criteria.
View Article and Find Full Text PDFExpert Rev Anticancer Ther
September 2024
Department of Experimental Therapeutics, National Cancer Center Hospital, Tokyo, Japan.
Background: ABBV-184, a novel survivin peptide-targeting T-cell receptor (TCR)/anti-CD3 bispecific protein, demonstrated preclinical T-cell activation and cytotoxicity toward HLA-A2:01-positive tumor lines. This first-in-human trial evaluated ABBV-184 monotherapy in patients with acute myeloid leukemia (AML) and non-small cell lung cancer (NSCLC).
Research Design And Methods: This phase 1 multicenter, open-label, dose escalation trial (NCT04272203) enrolled adult patients with relapsed/refractory AML or NSCLC with an HLA-A2:01 restricted genotype.
J Extracell Biol
August 2023
Nantes Université, Inserm UMR 1307, CNRS UMR 6075, Université d'Angers CRCI2NA Nantes France.
Non-coding RNAs (ncRNAs) are important regulators of gene expression. They are expressed not only in cells, but also in cell-derived extracellular vesicles (EVs). The mechanisms controlling their loading and sorting remain poorly understood.
View Article and Find Full Text PDFJ Stroke Cerebrovasc Dis
November 2024
Department of Anesthesiology and Intensive Care, University Hospital of Angers, Angers 49100, France; INSERM UMR 1246-SPHERE, Nantes University, Tours University, Nantes, France. Electronic address:
Introduction: Mechanical thrombectomy (MT) is the standard of care for the treatment of acute ischemic stroke (AIS) with large vessel occlusion (LVO), but unfavorable outcomes remain common. Procedural arterial hypotension is associated with poor patient outcome. This study aimed to assess the impact of arterial hypotension "magnitude" (a combination of the depth, defined as the percentage relative to baseline arterial blood pressure, and the duration of hypotensive episodes)" during MT on neurological outcome.
View Article and Find Full Text PDFJ Eur Acad Dermatol Venereol
July 2024
Pierre Fabre Médicament, Boulogne-Billancourt, France.
In recent years, new approaches for optimal patient management of cancer have focused on patient-centered care, with integration of tumour-directed treatment and patient-directed supportive and palliative care throughout the disease journey from prevention through screening, diagnosis, treatment, and follow-up. In 2022, at the International Forum of Dermatology (IFD), a scientific session was entirely dedicated to highlight recent developments on patient-centered approaches in skin cancer. An international panel of different groups of participants involved in a patient's journey on the management of skin cancer presented and discussed challenges and barriers that persist in the field of skin cancer prevention and care pathways.
View Article and Find Full Text PDF